Abiopharma

Publication date of the Q2 2026 Periodic report on 20.8.26, investors’ call on the same day at 11:00

Virtuix Reports Fiscal Year 2026 Results as Meta Launch, Defense Momentum and AI Initiatives Expand Growth Opportunities

Streamline Spacecraft Timing Architecture with Microchip’s Radiation-Tolerant, Low-Power, Low-Jitter Six-Output Clock Generator

Agilent Technologies, Inc. - Agilent Completes Acquisition of Biocare Medical

United Natural Foods Spotlights Top Industry Trends and Innovations to Help Grocery Retailers Differentiate this Holiday and Winter Selling Season

Medical Manufacturing Technologies (MMT) Appoints Grant Bowman as President to Lead the Companys Next Chapter of Growth and Innovation

Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)

Extreme Unveils Industry’s First Multi-Beam Wi-Fi Solution, Delivering Unprecedented Capacity and Performance in Large Venues

NANO Nuclear’s KRONOS MMR™ Program Advances as U.S. NRC Initiates Formal Review Activities with University of Illinois Urbana-Champaign and NANO Nuclear Energy

BGC Group Updates its Outlook for the Second Quarter of 2026